EXAS

Exact Sciences Corporation

Halal Rating :
Comfortable
Last Price $51.73 Last updated:
Market Cap $11.4b
7D Change -11.59%
1 Year Change -21.63%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Services
  • Healthcare
  • Services – Health
Exchange NASDAQ
Next Earnings Date Oct. 30, 2024

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of cancer. The company's flagship product is Cologuard, a non-invasive screening test for colorectal cancer and pre-cancer. They also offer other cancer screening and diagnostic tests through their Precision Oncology portfolio.

The company develops and commercializes cancer screening and diagnostic tests that help patients get the answers they need to make important decisions about their health. Their product portfolio includes tests for multiple types of cancers, leveraging advanced technologies in molecular diagnostics.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $708.65m $757.66m - $9.61m 0.00% 1.27%
June 30, 2024 $699.26m $725.41m - $-111000.0 0.00% 0.02%
March 31, 2024 $637.52m $752.16m - $7.94m 0.00% 1.06%

Company Impact

Help us evaluate Exact Sciences Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates